Leavitt Chase C. - Insider Non-Derivative Transactions at Oncternal Therapeutics, Inc. (ONCT) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Jan 3, 2024, Leavitt Chase C.'s relationship to Oncternal Therapeutics, Inc. (ONCT) is Officer (General Counsel/Secretary), and currently has 84,758 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ONCT insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Leavitt Chase C. - Insider Non-Derivative Transactions of ONCT Common Stock

Leavitt Chase C. - Insider Non-Derivative Transactions at ONCT

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Jan 4, 2024	F -- (Common Stock)	11838	0.5	84758
Jul 4, 2023	F -- (Common Stock)	10305	0.36	96596
Apr 14, 2023	P -- (Common Stock)	10000	0.29	106901
Apr 13, 2023	P -- (Common Stock)	15000	0.29	96901
Jan 4, 2023	F -- (Common Stock)	6091	1.02	81901